The Centers for Disease Control and Prevention (CDC), along with the PA Department of Health and County Health Departments, are closely monitoring the progression of the 2019 novel coronavirus pandemic. Main Line Health is following all the necessary guidelines put forth by the CDC and the World Health Organization (WHO) to protect our patients and colleagues. Learn more about the novel coronavirus.
Lankenau Medical Center hosts Multidisciplinary International Rectal Cancer Society (MIRCS) Symposium
Lankenau Medical CenterMay 16, 2019News Releases
International leaders within the field of colorectal cancer meet to discuss innovations in treatment and outcomes
Lankenau Medical Center, part of Main Line Health, hosted the Multidisciplinary International Rectal Cancer Society (MIRCS) symposium on May 1-3 that featured research updates, clinical presentations, and panel discussions by international leaders in the field of rectal cancer, with a focus on evolving strategies for optimizing oncologic and quality of life outcomes of care. During the three-day symposium, a live Transanal Total Mesorectal Excision (taTME) procedure, which originated at Lankenau and uses a so-called “bottom-up approach” in which dissection of the affected tissues is started transanally rather than through the abdomen in order to improve the cancer surgery, was telecasted to the audience. The surgery was performed by Symposium Director John H. Marks, MD. This was followed by didactic lectures from an all-star, international faculty and then the participants performed the surgery on a cadaveric model to master the procedure themselves.
“It was an honor to host this incredible symposium, which brought together 75 physicians from 15 countries and four continents who are all dedicated to moving the needle forward for rectal and colorectal cancer patients across the globe,” says John H. Marks, MD, renowned colorectal surgeon who serves as the director of the Colorectal Center at Lankenau Medical Center and chief of the section of colorectal surgery at Main Line Health. “Throughout the course of the three-day meeting, physician experts in surgery, medical oncology, radiation oncology and radiology shared discussions and demonstrations of advanced techniques to treat colorectal cancers and to improve quality of life for patients.”
At Main Line Health, the Colorectal Center at Lankenau Medical Center serves as epicenter for the exploration, development and clinical application of advanced technology with emphasis on minimally invasive procedures. The center also provides a fellowship and advanced postgraduate educational programs for surgeons and multidisciplinary specialists, as well as informational services for health care personnel and the public. The Colorectal Center is led by Dr. Henry Schoonyoung and Dr. John Marks, who has pioneered significant breakthroughs that are now considered worldwide standards of care for colorectal cancer, including the Transanal Abdominal Transanal Radical Proctosigmoidectomy (TATA), a surgical procedure that not only removes colorectal cancer, but preserves sphincter function, preventing the need for a colostomy bag.
Founded in 1985, Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health’s commitment—to deliver advanced medicine to treat and cure disease while also playing an essential role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.
At Main Line Health’s core are four of the region’s most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which provides skilled home health care, hospice and home infusion services; Main Line Health centers, which feature primary and specialty care, lab and radiology, among other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region’s largest multi-specialty physician networks.
Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation’s highest distinction for nursing excellence, and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association’s #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.
About Lankenau Medical Center
Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau Medical Center has been named among the top 10 hospitals in Pennsylvania and top five in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals 2019–20, and was ranked as high-performing in abdominal aortic aneurysm repair, aortic valve surgery, colon cancer surgery, gastroenterology & GI surgery, geriatrics, heart bypass surgery, heart failure, hip replacement, knee replacement, lung cancer surgery and nephrology. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.